Use of Thalamus L-Sign to Differentiate Periventricular Leukomalacia From Neurometabolic Disorders
Journal of Child Neurology · 2023
DOI: 10.1177/08830738231168973 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Child Neurology, 2023. Verfasst von Sabahattin Yuzkan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey. Hauptthemen laut MEDLINE: Brain Diseases, Metabolic, Leukomalacia, Periventricular, Thalamus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Purpose
To assess the diagnostic value of the thalamus L-sign on magnetic resonance imaging (MRI) in distinguishing between periventricular leukomalacia and neurometabolic disorders in pediatric patients.
Methods
In this retrospective study, clinical and imaging information was collected from 50 children with periventricular leukomalacia and 52 children with neurometabolic disorders. MRI was used to evaluate the L-sign of the thalamus (ie, injury to the posterolateral thalamus) and the lobar distribution of signal intensity changes. Age, sex, gestational age, and level of Gross Motor Function Classification System (only for periventricular leukomalacia) constituted the clinical parameters. Statistical evaluation of group differences for imaging and clinical variables were conducted using univariable statistical methods. The intra- and inter-observer agreement was evaluated using Cohen's kappa. Univariable or multivariable logistic regression was employed for selection of variables, determining independent predictors, and modeling.
Results
The thalamus L-sign was observed in 70% (35/50) of patients in the periventricular leukomalacia group, but in none of the patients with neurometabolic disorder ( P < .001). The gestational age between groups varied significantly ( P < .001). Involvement of frontal, parietal, and occipital lobes differed significantly between groups ( P < .001). In the logistic regression, the best model included negative thalamus L-sign and gestational age, yielding an area under the curve, accuracy, sensitivity, specificity, and precision values of 0.995, 96.1%, 96%, 96.2%, and 96%, respectively. Both the lack of thalamus L-sign and gestational age were independent predictors ( P < .001).
Conclusions
The thalamus L-sign and gestational age may be useful in distinguishing between periventricular leukomalacia and neurometabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey.
- Department of Pediatric Inherited Metabolic Diseases, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey.
- Department of Pediatric Neurology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Turkey.
ORCID-Profile: Sabahattin Yuzkan, Merve Balci
Zitieren
APA
Yuzkan, S., Emecen Sanli, M., Balci, M., Cennetoglu, P., Kafadar, I., & Kocak, B. (2023). Use of Thalamus L-Sign to Differentiate Periventricular Leukomalacia From Neurometabolic Disorders. Journal of Child Neurology. https://doi.org/10.1177/08830738231168973
Vancouver
Yuzkan S, Emecen Sanli M, Balci M, Cennetoglu P, Kafadar I, Kocak B. Use of Thalamus L-Sign to Differentiate Periventricular Leukomalacia From Neurometabolic Disorders. Journal of Child Neurology. 2023. doi:10.1177/08830738231168973
BibTeX
@article{Yuzkan2023,
author = {Yuzkan, Sabahattin and Emecen Sanli, Merve and Balci, Merve and Cennetoglu, Pakize and Kafadar, Ihsan and Kocak, Burak},
title = {Use of Thalamus L-Sign to Differentiate Periventricular Leukomalacia From Neurometabolic Disorders},
journal = {Journal of Child Neurology},
year = {2023},
doi = {10.1177/08830738231168973}
}
EUVIMED